We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$177M
AUM Growth
+$18.7M
Cap. Flow
+$5.4M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
982
New
339
Increased
167
Reduced
226
Closed
62

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$1.5M
2
ARE icon
Alexandria Real Estate Equities
ARE
+$1.48M
3
SON icon
Sonoco
SON
+$1.42M
4
R icon
Ryder
R
+$1.39M
5
AMT icon
American Tower
AMT
+$1.38M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.78M
2
IBM icon
IBM
IBM
+$1.56M
3
INGR icon
Ingredion
INGR
+$1.48M
4
ELV icon
Elevance Health
ELV
+$1.47M
5
MDT icon
Medtronic
MDT
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Real Estate 18.63%
3 Industrials 12.95%
4 Healthcare 10.2%
5 Consumer Staples 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
626
Ultragenyx Pharmaceutical
RARE
$2.66B
$3.29K ﹤0.01%
71
PFGC icon
627
Performance Food Group
PFGC
$17.9B
$3.27K ﹤0.01%
+56
New +$3.05K
WHD icon
628
Cactus
WHD
$5.78B
$3.27K ﹤0.01%
+65
New +$3.26K
CLDX icon
629
Celldex Therapeutics
CLDX
$3.48B
$3.25K ﹤0.01%
73
ALB icon
630
Albemarle
ALB
$15.3B
$3.25K ﹤0.01%
+15
New +$4K
DGRO icon
631
iShares Core Dividend Growth ETF
DGRO
$43.7B
$3.25K ﹤0.01%
65
MDXG icon
632
MiMedx Group
MDXG
$630M
$3.24K ﹤0.01%
1,166
CCL icon
633
Carnival Corporation Ltd
CCL
$38B
$3.22K ﹤0.01%
400
-104
-21% -$896
FDS icon
634
Factset
FDS
$10.1B
$3.21K ﹤0.01%
+8
New +$3.41K
PXD
635
DELISTED
Pioneer Natural Resource Co.
PXD
$3.2K ﹤0.01%
+14
New +$3.41K
DGII icon
636
Digi International
DGII
$3.17B
$3.18K ﹤0.01%
+87
New +$3.35K
CSTL icon
637
Castle Biosciences
CSTL
$985M
$3.18K ﹤0.01%
+135
New +$3.13K
MSA icon
638
Mine Safety
MSA
$7.44B
$3.17K ﹤0.01%
+22
New +$2.88K
ACAD icon
639
Acadia Pharmaceuticals
ACAD
$5.07B
$3.17K ﹤0.01%
199
-82
-29% -$1.28K
GXO icon
640
GXO Logistics
GXO
$5.37B
$3.12K ﹤0.01%
73
CC icon
641
Chemours
CC
$2.23B
$3.06K ﹤0.01%
100
COIN icon
642
Coinbase
COIN
$39.2B
$3.04K ﹤0.01%
86
-53
-38% -$2.79K
CDW icon
643
CDW
CDW
$16.9B
$3.04K ﹤0.01%
+17
New +$2.99K
BLU
644
DELISTED
BELLUS Health Inc.
BLU
$3.02K ﹤0.01%
368
CSGP icon
645
CoStar Group
CSGP
$12.6B
$3.01K ﹤0.01%
+39
New +$3.05K
ACGL icon
646
Arch Capital
ACGL
$33.5B
$3.01K ﹤0.01%
+48
New +$2.68K
WABC icon
647
Westamerica Bancorp
WABC
$1.36B
$3.01K ﹤0.01%
+51
New +$3K
PGAL
648
DELISTED
Global X MSCI Portugal ETF
PGAL
$2.99K ﹤0.01%
+297
New +$2.86K
ETN icon
649
Eaton
ETN
$178B
$2.98K ﹤0.01%
19
-281
-94% -$43.1K
CFG icon
650
Citizens Financial Group
CFG
$30.7B
$2.95K ﹤0.01%
+75
New +$2.93K

Similar funds

Truvestments Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Truvestments Capital held 982 positions worth $177M, up 12% from $159M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital deployed $5.4M of net new capital in Q4 2022, opening 339 new positions and adding to 167 existing holdings. Its largest new stake was Coterra Energy: 54,452 shares worth $1.34M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $1.78M trimmed.

  • Truvestments Capital's largest Q4 2022 buy was Coterra Energy: 54,452 shares worth $1.34M.
  • Truvestments Capital added most to Alexandria Real Estate Equities in Q4 2022, an estimated $1.48M increase.
  • Truvestments Capital's biggest Q4 2022 reduction was AbbVie, cutting an estimated $1.78M.
  • Truvestments Capital fully exited Twitter, Inc. in Q4 2022, selling an estimated $374K.
  • Truvestments Capital's ten largest holdings make up 19% of its $177M portfolio in Q4 2022.
  • Truvestments Capital opened 339 new positions and closed 62 in Q4 2022.
  • Truvestments Capital's portfolio value rose 12% quarter-over-quarter to $177M.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.